These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6951470)

  • 1. The immunopathology of acquired myasthenia gravis.
    Engel AG; Sahashi K; Fumagalli G
    Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
    Engel AG; Lambert EH; Howard FM
    Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
    Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
    J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG; Lambert EH
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
    Sahashi K; Engel AG; Lambert EH; Howard FM
    J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of acetylcholine receptor loss from the neuromuscular junction.
    Engel AG; Fumagalli G
    Ciba Found Symp; 1982; (90):197-224. PubMed ID: 6923808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
    Fumagalli G; Engel AG; Lindstrom J
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
    Mossman S; Vincent A; Newsom-Davis J
    J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of myasthenic immunoglobulin G on motor end-plate morphology.
    Tsujihata M; Satoh A; Yoshimura T; Motomura M; Takeo G; Matsuo H; Nakamura T
    J Neurol; 2003 Jan; 250(1):75-82. PubMed ID: 12527996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathologic events at the endplate in myasthenia gravis.
    Ashizawa T; Appel SH
    Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
    Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
    Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
    Fazekas A; Komoly S; Bózsik B; Szobor A
    Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
    Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
    Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.